PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+10.06%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.08B
AUM Growth
+$3.08B
(-0.87%)
Cap. Flow
-$95.9M
Cap. Flow
% of AUM
-3.11%
Top 10 Holdings %
Top 10 Hldgs %
37.15%
Holding
94
New
12
Increased
13
Reduced
16
Closed
15
Top Buys
| 1 |
Erasca
ERAS
|
$98.2M |
| 2 |
Caribou Biosciences
CRBU
|
$88.2M |
| 3 |
Cytokinetics
CYTK
|
$52.6M |
| 4 |
SOPHiA GENETICS
SOPH
|
$35.5M |
| 5 |
AstraZeneca
AZN
|
$34.7M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$166M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$68.5M |
| 3 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$43.5M |
| 4 |
Baxter International
BAX
|
$36.9M |
| 5 |
Guardant Health
GH
|
$36.2M |
Sector Composition
| 1 | Healthcare | 94.98% |
| 2 | Financials | 0.3% |
